BDX · 8-K · 20260806PR053790

Market Demand Trends

BECTON DICKINSON & CO · 2026-08-06 · Importance 36 · Surprise 40

Third-quarter revenue increased 5.4% year over year to $4,983 million, or 4.4% on a foreign-currency-neutral basis. Medical Essentials revenue rose 4.5% to $1,675 million, Connected Care increased 4.9% to $1,224 million, BioPharma Systems grew 6.6% to $670 million, and Interventional increased 6.4% to $1,414 million. Within the businesses, Advanced Patient Monitoring revenue grew 10.9% to $309 million, while Surgery revenue increased 7.0% to $422 million and Peripheral Intervention rose 7.8% to $552 million.